Cargando…
Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
Psoriasis (PS) is a chronic skin inflammation. Up to 30% of the patients with PS develop psoriatic arthritis (PsA), a condition characterized by inflammatory arthritis that affects joints or entheses. Although there is mounting evidence for a critical role of interleukin-23 (IL-23) signaling in the...
Autores principales: | Chen, Lili, Deshpande, Madhura, Grisotto, Marcos, Smaldini, Paola, Garcia, Roberto, He, Zhengxiang, Gulko, Percio S., Lira, Sergio A., Furtado, Glaucia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237669/ https://www.ncbi.nlm.nih.gov/pubmed/32427877 http://dx.doi.org/10.1038/s41598-020-65269-6 |
Ejemplares similares
-
Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23
por: Chen, Lili, et al.
Publicado: (2019) -
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018) -
The role of IL‐23 and the use of IL‐23 inhibitors in psoriatic arthritis
por: Fragoulis, George E., et al.
Publicado: (2022) -
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
por: Yang, Kevin, et al.
Publicado: (2020) -
Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc(Min/+) mice
por: He, Zhengxiang, et al.
Publicado: (2017)